Caffeoylated Phenylpropanoid Glycosides from Brandisia hancei Inhibit Advanced Glycation End Product Formation and Aldose Reductase in Vitro and Vessel Dilation in Larval Zebrafish in Vivo
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yu, Song Yi | - |
dc.contributor.author | Lee, Ik-Soo | - |
dc.contributor.author | Jung, Seung-Hyun | - |
dc.contributor.author | Lee, Yun Mi | - |
dc.contributor.author | Lee, Yu-Ri | - |
dc.contributor.author | Kim, Joo-Hwan | - |
dc.contributor.author | Sun, Hang | - |
dc.contributor.author | Kim, Jin Sook | - |
dc.date.available | 2020-02-28T22:42:11Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2013-12 | - |
dc.identifier.issn | 0032-0943 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/14064 | - |
dc.description.abstract | In our continuing efforts to identify effective naturally sourced agents for diabetic complications, five caffeoylated phenylpropanoid glycosides, acteoside (1), isoacteoside (2), poliumoside (3), brandioside (4), and pheliposide (5) were isolated from the 80% EtOH extract of Brandisia hancei stems and leaves. These isolates (1-5) were subjected to an in vitro bioassay evaluating their inhibitory activity on advanced glycation end product formation and rat lens aldose reductase activity. All tested compounds exhibited significant inhibition of advanced glycation end product formationwith IC50 values of 4.6-25.7 mu M, compared with those of aminoguanidine (IC50 = 1056 mu M) and quercetin (IC50 = 28.4 mu M) as positive controls. In the rat lens aldose reductase assay, acteoside, isoacteoside, and poliumoside exhibited greater inhibitory effects on rat lens aldose reductase with IC50 values of 0.83, 0.83, and 0.85 mu M, respectively, than those of the positive controls, 3,3-tetramethyleneglutaric acid (IC50= 4.03 mu M) and quercetin (IC50 = 7.2 mu M). In addition, the ef-fect of acteoside on the dilation of hyaloid-retinal vessels induced by high glucose in larval zebrafish was investigated. Acteoside reduced the diameters of high glucose-induced hyaloid-retinal vessels by 69% at 10 mu Mand 81% at 20 mu M, compared to the high glucose-treated control group. These results suggest that B. hancei and its active components might be beneficial in the treatment and prevention of diabetic vascular complications. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | GEORG THIEME VERLAG KG | - |
dc.relation.isPartOf | PLANTA MEDICA | - |
dc.subject | PROTEIN GLYCATION | - |
dc.subject | STRUCTURAL REQUIREMENTS | - |
dc.subject | DIABETIC COMPLICATIONS | - |
dc.subject | MEDICINAL-PLANTS | - |
dc.subject | CATARACTOGENESIS | - |
dc.subject | PURIFICATION | - |
dc.subject | FLAVONOIDS | - |
dc.subject | SEEDS | - |
dc.subject | ACID | - |
dc.subject | AGES | - |
dc.title | Caffeoylated Phenylpropanoid Glycosides from Brandisia hancei Inhibit Advanced Glycation End Product Formation and Aldose Reductase in Vitro and Vessel Dilation in Larval Zebrafish in Vivo | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000328696600003 | - |
dc.identifier.doi | 10.1055/s-0033-1351101 | - |
dc.identifier.bibliographicCitation | PLANTA MEDICA, v.79, no.18, pp.1705 - 1709 | - |
dc.identifier.scopusid | 2-s2.0-84890986090 | - |
dc.citation.endPage | 1709 | - |
dc.citation.startPage | 1705 | - |
dc.citation.title | PLANTA MEDICA | - |
dc.citation.volume | 79 | - |
dc.citation.number | 18 | - |
dc.contributor.affiliatedAuthor | Kim, Joo-Hwan | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Brandisia hancei | - |
dc.subject.keywordAuthor | Scrophulariaceae | - |
dc.subject.keywordAuthor | phenylpropanoid glycoside | - |
dc.subject.keywordAuthor | advanced glycation end-product | - |
dc.subject.keywordAuthor | rat lens aldose reductase | - |
dc.subject.keywordAuthor | zebrafish | - |
dc.subject.keywordAuthor | diabetic vascular complications | - |
dc.subject.keywordPlus | PROTEIN GLYCATION | - |
dc.subject.keywordPlus | STRUCTURAL REQUIREMENTS | - |
dc.subject.keywordPlus | DIABETIC COMPLICATIONS | - |
dc.subject.keywordPlus | MEDICINAL-PLANTS | - |
dc.subject.keywordPlus | CATARACTOGENESIS | - |
dc.subject.keywordPlus | PURIFICATION | - |
dc.subject.keywordPlus | FLAVONOIDS | - |
dc.subject.keywordPlus | SEEDS | - |
dc.subject.keywordPlus | ACID | - |
dc.subject.keywordPlus | AGES | - |
dc.relation.journalResearchArea | Plant Sciences | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Integrative & Complementary Medicine | - |
dc.relation.journalWebOfScienceCategory | Plant Sciences | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Integrative & Complementary Medicine | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.